Definitive Contract 75N91023C00034
Award Date
8/7/23
Potential Completion Date
8/6/24
Potential Value
$14K
Federal Agency
National Cancer Institute
Awardee
Zymeron Corporation
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $389,973 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Ai Biosciences, Inc., a small disadvantaged biotechnology company. The contract is for the development of a "Rapid Isothermal Amplification Chip for HPV Detection and Genotyping in Low-Resource Settings." This aligns with NCI's mission to support cancer research and diagnostic technologies,...
Zymeron Corporation was awarded a $400,000 firm fixed price definitive contract by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to develop user-friendly technologies and devices to create an at-home Hepatitis C virus test under the Small Business Innovation Research Program Topic 441. As a small business concern, Zymeron will conduct the research and development effort at its facilities in Research Triangle Park, North Carolina through...
This is a $299,988 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Zymeron Corporation, a minority-owned small business. The contract is for the development of novel, low-cost, real-time point-of-care (POC) assays for HIV viral load monitoring, HIV drug resistance monitoring, and pharmacological adherence monitoring. This contract was awarded under the Small Business Innovation...
This is a $382,034 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Phoenix Biosystem, Inc., a self-certified small disadvantaged business. The contract is for the development of HPV point-of-care molecular diagnostics for low- and middle-income countries. The original pre-solicitation announced that NIH and CDC were seeking SBIR proposals to advance their infectious...
The Zymeron Corporation was awarded a $299,998 firm fixed price Small Business Innovation Research Program Phase I contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for the research and development of a rapid point-of-care diagnostic test for histoplasmosis. This award falls under the larger SBIR solicitation issued by NIH and CDC seeking proposals in areas including cancer immunotherapy manufacturing, opioid withdrawal...
<p>The National Cancer Institute, a civilian federal agency, awarded a $1,099,452.64 cost-plus-fixed-fee definitive contract to Zymera Inc., a self-certified small disadvantaged business, for a "HOMOGENEOUS NANO PARTICLE - BASED ASSAYS FOR PROTEASE DETECTION" research and development project under SBIR Phase II Topic No. 266. The contract was set aside for small businesses and has a completion date of June 24, 2015.</p>
This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Pointcare Genomics Corp, a small minority-owned business, for research and development in biomedical basic research. The contract is a definitive, firm-fixed price contract valued at $299,961.00 and is part of the SBIR (Small Business Innovation Research) Program Phase I. The contract has a total small business set-aside designation and was awarded on September 22, 2015, with a completion date of...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,272,000.00 Firm Fixed Price, Definitive Contract to Zymeron Corporation, a minority-owned, for-profit biotechnology company. The contract is for the development of "Rapid Point of Care Tests to Simultaneously Quantify Anti-TB Drugs in Blood" under the Small Business Innovation Research (SBIR) Program Phase II. This research aligns with the...
This federal contract award, with an ID of 75N91021P00756, was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The $95,995 firm-fixed-price purchase order was awarded to Atila Biosystems Incorporated, a small business, to provide HPV genotyping assays and testing supplies to support the NCI's Division of Cancer Epidemiology and Genetics (DCEG) research efforts. The contract was...
This is a $299,998.00 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Zymeron Corporation, a Minority Owned small business, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development related to "Combinatory Treatment Modalities Utilizing Radiation to Locally Activate or Release Systemically Delivered Therapeutics", as part of SBIR Topic...